Lexaria Bioscience (LXRP) Short Interest Ratio & Short Volume

Short interest is the volume of Lexaria Bioscience shares that have been sold short but have not yet been covered or closed out. As of January 15th, traders have sold 33,600 shares of LXRP short. Learn More on Lexaria Bioscience's current short interest.

Lexaria Bioscience saw a increase in short interest in January. As of January 15th, there was short interest totaling 33,600 shares, an increase of 138.3% from the previous total of 14,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to Lexaria Bioscience: Poxel S.A. (0.00%), ETAO International Co., Ltd. (2.93%), Streamline Health Solutions, Inc. (0.10%), Lumos Pharma, Inc. (5.94%), Aptose Biosciences Inc. (0.92%), Covalon Technologies Ltd. (0.02%), KALA BIO, Inc. (0.25%), FSD Pharma Inc. (2.06%), Curative Biotechnology, Inc. (0.00%), BioVie Inc. (3.71%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($6.62 billion), Analog Devices, Inc. ($4.85 billion), Aon plc ($4.66 billion), DuPont de Nemours, Inc. ($3.84 billion), International Flavors & Fragrances Inc. ($3.60 billion), Moderna, Inc. ($3.22 billion), Snap Inc. ($3.21 billion), Snowflake Inc. ($2.82 billion), The Kroger Co. ($2.52 billion), and Peloton Interactive, Inc. ($2.51 billion). View all of the most shorted stocks.

Short selling LXRP is an investing strategy that aims to generate trading profit from Lexaria Bioscience as its price is falling. LXRP shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Lexaria Bioscience occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LXRP, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LXRP, twice per month. The most recent reporting period available is January, 15 2021.